AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29063518 — intervention group
Group type: EXPERIMENTAL
Intervention: ALZ-801 with food
Number of subjects: 127
Study 29063518 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release tablet formulation of ALZ-801
Number of subjects: 127
Study 26842771 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g freeze-dried whole strawberry powder (FDS)
Number of subjects: 21
Study 26842771 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g freeze-dried whole strawberry powder (FDS)
Number of subjects: 21
Study 26842771 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g freeze-dried whole strawberry powder (FDS)
Number of subjects: 21
Study 26842771 — intervention group
Group type: COMPARATOR
Intervention: 0 g freeze-dried whole strawberry powder (FDS, control)
Number of subjects: 21
Study 26695407 — intervention group
Group type: EXPERIMENTAL
Intervention: 5As Team intervention (5AsT); delivered in a series of 12 workshops; content based on 43 topics related to 13 themes around obesity assessment and management.
Number of subjects: 0
Study 26695407 — intervention group
Group type: EXPERIMENTAL
Intervention: 5As Team intervention (5AsT); included videos, resources, and tools.
Number of subjects: 0
Study 23732992 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive intervention (MII) involving aspirating iliac crest bone marrow and peripheral blood to yield mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP), mixed with demineralized bone matrix (DBM) and injected into the fracture site.
Number of subjects: 24
Study 23732992 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 24
Study 20148270 — intervention group
Group type: EXPERIMENTAL
Intervention: ESAs alone
Number of subjects: 286
Study 20148270 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ESAs and parenteral iron
Number of subjects: 286
Study 20148270 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron only
Number of subjects: 286
Study 20148270 — intervention group
Group type: EXPERIMENTAL
Intervention: Normochromic patients treated with ESAs alone
Number of subjects: 286
Study 17971261 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg escitalopram
Number of subjects: 18
Study 17971261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 16896685 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-order wavefront analysis using discriminant analysis from PISD and Zernike coefficients
Number of subjects: 8
Study 16896685 — intervention group
Group type: COMPARATOR
Intervention: Single Zernike coefficients
Number of subjects: 8
Study 16896685 — intervention group
Group type: EXPERIMENTAL
Intervention: Discriminant functions based on PISD and higher-order Zernike coefficients
Number of subjects: 8
Study 14533837 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg on day 1, followed by 250 mg once a day on days 2 to 5)
Number of subjects: 296
Study 14533837 — intervention group
Group type: COMPARATOR
Intervention: Cefadroxil (500 mg twice a day for 10 days)
Number of subjects: 296
Study 14533837 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 296
Study 14533837 — intervention group
Group type: COMPARATOR
Intervention: Cefadroxil
Number of subjects: 296
Study 10779658 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin injection (50 microg)
Number of subjects: 9
Study 10779658 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-force stimuli (16, 32, and 64 g) applied via a 12-mm wide, 100-microm thick blade probe
Number of subjects: 9
Study 10779658 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held 20-g von Frey probe
Number of subjects: 9
Study 9235663 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 62
Study 9235663 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine
Number of subjects: 62
Study 1529745 — intervention group
Group type: EXPERIMENTAL
Intervention: des‐enkephalin‐gamma‐endorphin (DE‐gamma‐E) 10 mg given as a once daily intramuscular injection for 4 weeks
Number of subjects: 96
Study 1529745 — intervention group
Group type: EXPERIMENTAL
Intervention: thioridazine 400 mg orally in 2 divided doses
Number of subjects: 96
Study 1529745 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 96
Study 1529745 — intervention group
Group type: EXPERIMENTAL
Intervention: thioridazine
Number of subjects: 96
Study 2856778 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (hydrochlorothiazide + triamterene)
Number of subjects: 840
Study 2856778 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 840
Study 30059989 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-27 (IL-27) plasma levels
Number of subjects: 153
Study 30059989 — intervention group
Group type: EXPERIMENTAL
Intervention: Microarray results confirmed by quantitative PCR and ELISA
Number of subjects: 153
Study 30059989 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer pathway gene expression data
Number of subjects: 153
Study 30227092 — intervention group
Group type: EXPERIMENTAL
Intervention: Etched with hydrofluoric (HF) acid
Number of subjects: 90
Study 30227092 — intervention group
Group type: EXPERIMENTAL
Intervention: Etched with Er:YAG laser at 250mJ, 20Hz
Number of subjects: 90
Study 30227092 — intervention group
Group type: EXPERIMENTAL
Intervention: Etched with Er:YAG laser at 300mJ, 20Hz
Number of subjects: 90
Study 30227092 — intervention group
Group type: EXPERIMENTAL
Intervention: Etched with Er:YAG laser at 250mJ, 20Hz combined with HF etching
Number of subjects: 90
Study 30227092 — intervention group
Group type: EXPERIMENTAL
Intervention: Etched with Er:YAG laser at 300mJ, 20Hz combined with HF etching
Number of subjects: 90
Study 30227092 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 90
Study 26995375 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs)
Number of subjects: 1970
Study 24414607 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D 1,000 IU/day and elemental calcium 500 mg/day
Number of subjects: 41
Study 24414607 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 41
Study 24414607 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D and calcium co-administration
Number of subjects: 41
Study 24414607 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IG and CG)
Number of subjects: 41
Study 22369408 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 83
Study 22369408 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-tibolone (NT-group)
Number of subjects: 83
Study 22369408 — intervention group
Group type: COMPARATOR
Intervention: Control (premenoausal women)
Number of subjects: 83
Study 19752398 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 5804
Study 19752398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5804
Study 19752398 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 5804
Study 18506735 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin formulation 1
Number of subjects: 0
Study 18506735 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin formulation 2
Number of subjects: 0
Study 18506735 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin (used as internal standard)
Number of subjects: 0
Study 15947511 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour group therapy (CBGT), 12 two-hour sessions over 6 months
Number of subjects: 67
Study 15947511 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 67
Study 12853808 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.4 or 2 x 0.4 mg daily)
Number of subjects: 609
Study 12853808 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 609
Study 10601507 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophysiologically guided antiarrhythmic therapy (including drugs and implantable defibrillators)
Number of subjects: 704
Study 10601507 — intervention group
Group type: COMPARATOR
Intervention: No antiarrhythmic therapy
Number of subjects: 704
Study 10601507 — intervention group
Group type: EXPERIMENTAL
Intervention: Defibrillator treatment
Number of subjects: 704
Study 10601507 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophysiologically guided therapy with antiarrhythmic drugs
Number of subjects: 704
Study 10601507 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 704
Study 8109766 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume (HV) group: bupivacaine 0.125% with sufentanil 0.7 microgram/mL, 6-8 mL/h
Number of subjects: 60
Study 8109766 — intervention group
Group type: COMPARATOR
Intervention: Low-volume (LV) group: bupivacaine 0.75% with sufentanil 4 micrograms/mL, 1.0-1.3 mL/h
Number of subjects: 60
Study 8109766 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 3262973 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 0
Study 3262973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20034162 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium amobarbital
Number of subjects: 49
Study 20034162 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxydione
Number of subjects: 49
Study 20034162 — intervention group
Group type: EXPERIMENTAL
Intervention: Methamphetamine
Number of subjects: 49
Study 20034162 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 49
Study 29703024 — intervention group
Group type: EXPERIMENTAL
Intervention: JianPi HuaZhuo XingNao formula (JPHZXN)
Number of subjects: 72
Study 29703024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 28615261 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 μg/d vitamin D3 supplementation
Number of subjects: 206
Study 28615261 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 μg/d vitamin D3 supplementation
Number of subjects: 206
Study 28615261 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 μg/d vitamin D intake
Number of subjects: 206
Study 28615261 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 μg/d vitamin D intake
Number of subjects: 206
Study 28615261 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 μg/d vitamin D intake
Number of subjects: 206
Study 28615261 — intervention group
Group type: EXPERIMENTAL
Intervention: 28 μg/d vitamin D intake
Number of subjects: 206
Study 28615261 — intervention group
Group type: COMPARATOR
Intervention: 2 μg/d placebo
Number of subjects: 206
Study 24629419 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescribed position changes during colonoscope withdrawal
Number of subjects: 776
Study 24629419 — intervention group
Group type: COMPARATOR
Intervention: Usual care per endoscopist
Number of subjects: 776
Study 22436144 — intervention group
Group type: EXPERIMENTAL
Intervention: Helical Tomotherapy (HT) with a dose of 60 Gy/10 fractions
Number of subjects: 93
Study 22436144 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 93
Study 22436144 — intervention group
Group type: EXPERIMENTAL
Intervention: Helical Tomotherapy (HT)
Number of subjects: 93
Study 20421834 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatitan garments
Number of subjects: 14
Study 20421834 — intervention group
Group type: COMPARATOR
Intervention: Placebo garments
Number of subjects: 14
Study 18797657 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% ibopamine provocative test
Number of subjects: 25
Study 18797657 — intervention group
Group type: COMPARATOR
Intervention: Water drinking test
Number of subjects: 25
Study 15781547 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane-propofol (8% sevoflurane + 1.5 mg/kg IV propofol)
Number of subjects: 83
Study 15781547 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane alone (8%)
Number of subjects: 83
Study 15781547 — intervention group
Group type: COMPARATOR
Intervention: Propofol alone (3 mg/kg IV)
Number of subjects: 83
Study 14685951 — intervention group
Group type: EXPERIMENTAL
Intervention: Short education program about the disorder and lithium therapy (3 sessions)
Number of subjects: 26
Study 14685951 — intervention group
Group type: COMPARATOR
Intervention: Control group (no education program)
Number of subjects: 26
Study 10378490 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity laser therapy (1.06 microm neodymium:yttrium-aluminum-garnet laser, 542mW/cm2)
Number of subjects: 63
Study 10378490 — intervention group
Group type: COMPARATOR
Intervention: Control group (inactive laser probes)
Number of subjects: 63
Study 8749965 — intervention group
Group type: EXPERIMENTAL
Intervention: Lighted stylet
Number of subjects: 73
Study 8749965 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 73
Study 1430280 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health education (OHE) programme with systematic brushing practice
Number of subjects: 62
Study 1430280 — intervention group
Group type: COMPARATOR
Intervention: Control group (no OHE programme)
Number of subjects: 62
Study 3155992 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocardia rubra cell wall skeleton (N-CWS) treatment
Number of subjects: 119
Study 3155992 — intervention group
Group type: COMPARATOR
Intervention: Control group (chemotherapy)
Number of subjects: 119
Study 30980127 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-energy texture analysis
Number of subjects: 87
Study 30980127 — intervention group
Group type: COMPARATOR
Intervention: Single-energy (65 keV) texture evaluation
Number of subjects: 87
Study 30980127 — intervention group
Group type: COMPARATOR
Intervention: Iodine material decomposition maps
Number of subjects: 87
Study 29298800 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/day pemafibrate
Number of subjects: 166
Study 29298800 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg/day pemafibrate
Number of subjects: 166
Study 29298800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166
Study 27512321 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga program for 12 weeks
Number of subjects: 81
Study 27512321 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 81
Study 24847496 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush 1
Number of subjects: 60
Study 24847496 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush 2
Number of subjects: 60
Study 24847496 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush 3
Number of subjects: 60
Study 24847496 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush 4
Number of subjects: 60
Study 24847496 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental Floss (used after 2 weeks)
Number of subjects: 60
Study 22244150 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole prophylaxis (before 2008)
Number of subjects: 10474
Study 22244150 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin prophylaxis (after 2008)
Number of subjects: 10474
Study 22244150 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall PNB procedure
Number of subjects: 10474
Study 19934787 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine (TIV, Fluzone, sanofi pasteur; N = 915)
Number of subjects: 1375
Study 19934787 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N = 460)
Number of subjects: 1375
Study 17359405 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam/Fentanyl (M/F)
Number of subjects: 57
Study 17359405 — intervention group
Group type: COMPARATOR
Intervention: Midazolam/Ketamine (M/K)
Number of subjects: 57
Study 15660048 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol CR/XL
Number of subjects: 0
Study 15660048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12407781 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril/Indapamide (2 mg/0.625 mg)
Number of subjects: 471
Study 12407781 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (50 mg)
Number of subjects: 471
Study 10660864 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (C, n = 8)
Number of subjects: 22
Study 10660864 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo (P, n = 8)
Number of subjects: 22
Study 10660864 — intervention group
Group type: COMPARATOR
Intervention: Control (N, n = 6)
Number of subjects: 22
Study 7799021 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral etoposide phosphate (escalated from 50 mg/m2/d to 220 mg/m2/d for 5 days)
Number of subjects: 40
Study 7799021 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous etoposide phosphate
Number of subjects: 40
Study 7799021 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral etoposide phosphate
Number of subjects: 40
Study 1821833 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 10
Study 1821833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7044798 — intervention group
Group type: EXPERIMENTAL
Intervention: Benoxaprofen (600 mg once a day)
Number of subjects: 35
Study 7044798 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin (25 mg t.i.d.)
Number of subjects: 35
Study 30609441 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg daily for 2 weeks)
Number of subjects: 40
Study 30609441 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine discontinuation
Number of subjects: 40
Study 29132339 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day Cetrotide sc injection (0.25 mg/day) started on Day-0
Number of subjects: 48
Study 29132339 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Cetrotide therapy)
Number of subjects: 48
Study 27998859 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate infusion at 5 mg·kg‐1·h‐1
Number of subjects: 108
Study 27998859 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 108
Study 27998859 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate infusion
Number of subjects: 108
Study 27998859 — intervention group
Group type: COMPARATOR
Intervention: Magnesium sulphate infusion and Saline (control group)
Number of subjects: 108
Study 24468007 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 202
Study 24468007 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 202
Study 24468007 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL) vs Dihydroartemisinin-piperaquine (DP)
Number of subjects: 202
Study 24468007 — intervention group
Group type: COMPARATOR
Intervention: Temperature ≥38.0°C vs <37.0°C
Number of subjects: 202
Study 24468007 — intervention group
Group type: COMPARATOR
Intervention: Parasite density >20,000/μL vs <4,000/μL
Number of subjects: 202
Study 23000025 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet plus weight management
Number of subjects: 144
Study 23000025 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet alone
Number of subjects: 144
Study 23000025 — intervention group
Group type: COMPARATOR
Intervention: Usual Diet Controls
Number of subjects: 144
Study 23000025 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet adherence
Number of subjects: 144
Study 19617586 — intervention group
Group type: EXPERIMENTAL
Intervention: History of early correction for myopia as a child or young adult
Number of subjects: 101
Study 19617586 — intervention group
Group type: COMPARATOR
Intervention: No early correction for myopia
Number of subjects: 101
Study 18283926 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor environment
Number of subjects: 0
Study 18283926 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoor environment
Number of subjects: 0
Study 18283926 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual matching
Number of subjects: 0
Study 18283926 — intervention group
Group type: EXPERIMENTAL
Intervention: Blindwalking
Number of subjects: 0
Study 16435069 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 60
Study 16435069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 12218276 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridated topical gel (12500 ppm F, partly as NaF, Olafluor and Dectafluor, pH 4.5) + fluoridated toothpaste (1450 ppm F as NaF)
Number of subjects: 26
Study 12218276 — intervention group
Group type: COMPARATOR
Intervention: Fluoridated toothpaste (1450 ppm F as NaF) alone
Number of subjects: 26
Study 12218276 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridated topical gel + fluoridated toothpaste
Number of subjects: 26
Study 12218276 — intervention group
Group type: COMPARATOR
Intervention: Fluoridated toothpaste alone
Number of subjects: 26
Study 10800491 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy including platin-compounds (cisplatin, carboplatin) and podophyllotoxins (etoposide, teniposide)
Number of subjects: 0
Study 10800491 — intervention group
Group type: EXPERIMENTAL
Intervention: Platin-containing regimens with new agents (gemcitabine, taxenes, navelbine)
Number of subjects: 0
Study 10800491 — intervention group
Group type: EXPERIMENTAL
Intervention: Topotecan and paclitaxel
Number of subjects: 0
Study 10800491 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative and preirradiatory chemotherapy
Number of subjects: 0
Study 7540812 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.2% hypertonic saline/6% hetastarch
Number of subjects: 26
Study 7540812 — intervention group
Group type: COMPARATOR
Intervention: 6% hetastarch (control)
Number of subjects: 26
Study 2354297 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular surveillance using an activities of daily living questionnaire administered by volunteers
Number of subjects: 539
Study 2354297 — intervention group
Group type: COMPARATOR
Intervention: Control group (no regular surveillance)
Number of subjects: 539
Study 403421 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Actovegin
Number of subjects: 114
Study 403421 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 114
Study 30387273 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive yes/no questions
Number of subjects: 249
Study 30387273 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsuccessful redirectives
Number of subjects: 249